{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T15:36:16Z","timestamp":1781105776802,"version":"3.54.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,12]],"date-time":"2023-12-12T00:00:00Z","timestamp":1702339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,12,12]],"date-time":"2023-12-12T00:00:00Z","timestamp":1702339200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100010677","name":"H2020 Health","doi-asserted-by":"publisher","award":["779340"],"award-info":[{"award-number":["779340"]}],"id":[{"id":"10.13039\/100010677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010677","name":"H2020 Health","doi-asserted-by":"publisher","award":["779340"],"award-info":[{"award-number":["779340"]}],"id":[{"id":"10.13039\/100010677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010677","name":"H2020 Health","doi-asserted-by":"publisher","award":["779340"],"award-info":[{"award-number":["779340"]}],"id":[{"id":"10.13039\/100010677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010677","name":"H2020 Health","doi-asserted-by":"publisher","award":["779340"],"award-info":[{"award-number":["779340"]}],"id":[{"id":"10.13039\/100010677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010677","name":"H2020 Health","doi-asserted-by":"publisher","award":["779340"],"award-info":[{"award-number":["779340"]}],"id":[{"id":"10.13039\/100010677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010677","name":"H2020 Health","doi-asserted-by":"publisher","award":["779340"],"award-info":[{"award-number":["779340"]}],"id":[{"id":"10.13039\/100010677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010677","name":"H2020 Health","doi-asserted-by":"publisher","award":["779340"],"award-info":[{"award-number":["779340"]}],"id":[{"id":"10.13039\/100010677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010677","name":"H2020 Health","doi-asserted-by":"publisher","award":["779340"],"award-info":[{"award-number":["779340"]}],"id":[{"id":"10.13039\/100010677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010677","name":"H2020 Health","doi-asserted-by":"publisher","award":["779340"],"award-info":[{"award-number":["779340"]}],"id":[{"id":"10.13039\/100010677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010677","name":"H2020 Health","doi-asserted-by":"publisher","award":["779340"],"award-info":[{"award-number":["779340"]}],"id":[{"id":"10.13039\/100010677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010677","name":"H2020 Health","doi-asserted-by":"publisher","award":["779340"],"award-info":[{"award-number":["779340"]}],"id":[{"id":"10.13039\/100010677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["KK.01.1.1.01.0008"],"award-info":[{"award-number":["KK.01.1.1.01.0008"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["KK.01.1.1.01.0008"],"award-info":[{"award-number":["KK.01.1.1.01.0008"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["KK.01.1.1.01.0008"],"award-info":[{"award-number":["KK.01.1.1.01.0008"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"name":"FP7 Health Program","award":["HEALTH\u2010F4\u20102011\u2010279239"],"award-info":[{"award-number":["HEALTH\u2010F4\u20102011\u2010279239"]}]},{"name":"FP7 Health Program","award":["HEALTH\u2010F4\u20102011\u2010279239"],"award-info":[{"award-number":["HEALTH\u2010F4\u20102011\u2010279239"]}]},{"name":"FP7 Health Program","award":["HEALTH\u2010F4\u20102011\u2010279239"],"award-info":[{"award-number":["HEALTH\u2010F4\u20102011\u2010279239"]}]},{"name":"FP7 Health Program","award":["HEALTH\u2010F4\u20102011\u2010279239"],"award-info":[{"award-number":["HEALTH\u2010F4\u20102011\u2010279239"]}]},{"name":"FP7 Health Program","award":["HEALTH\u2010F4\u20102011\u2010279239"],"award-info":[{"award-number":["HEALTH\u2010F4\u20102011\u2010279239"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Posterolateral spinal fusion (PLF) is a procedure used for the treatment of degenerative spine disease. In this study we evaluated Osteogrow-C, a novel osteoinductive device comprised of recombinant human Bone morphogenetic protein 6 (rhBMP6) dispersed in autologous blood coagulum with synthetic ceramic particles, in the sheep PLF model. Osteogrow-C implants containing 74\u2013420 or 1000\u20131700\u00a0\u00b5m ceramic particles (TCP\/HA 80\/20) were implanted between L4\u2013L5 transverse processes in sheep (<jats:italic>Ovis Aries<\/jats:italic>, Merinolaandschaf breed). In the first experiment (n\u2009=\u20099 sheep; rhBMP6 dose 800\u00a0\u00b5g) the follow-up period was 27 weeks while in the second experiment (n\u2009=\u200912 sheep; rhBMP6 dose 500\u00a0\u00b5g) spinal fusion was assessed by in vivo CT after 9 weeks and at the end of the experiment after 14 (n\u2009=\u20096 sheep) and 40 (n\u2009=\u20096 sheep) weeks. Methods of evaluation included microCT, histological analyses and biomechanical testing. Osteogrow-C implants containing both 74\u2013420 and 1000\u20131700\u00a0\u00b5m ceramic particles induced radiographic solid fusion 9 weeks following implantation. <jats:italic>Ex-vivo<\/jats:italic> microCT and histological analyses revealed complete osseointegration of newly formed bone with adjacent transverse processes. Biomechanical testing confirmed that fusion between transverse processes was complete and successful. Osteogrow-C implants induced spinal fusion in sheep PLF model and therefore represent a novel therapeutic solution for patients with degenerative disc disease.<\/jats:p>","DOI":"10.1038\/s41598-023-48878-9","type":"journal-article","created":{"date-parts":[[2023,12,12]],"date-time":"2023-12-12T18:05:52Z","timestamp":1702404352000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Calcium phosphate ceramics combined with rhBMP6 within autologous blood coagulum promote posterolateral lumbar fusion in sheep"],"prefix":"10.1038","volume":"13","author":[{"given":"Natalia","family":"Ivanjko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikola","family":"Stokovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marko","family":"Pecin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Drazen","family":"Vnuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Smajlovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niko","family":"Ivkic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hrvoje","family":"Capak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Javor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoran","family":"Vrbanac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Drazen","family":"Maticic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4076-0285","authenticated-orcid":false,"given":"Slobodan","family":"Vukicevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,12]]},"reference":[{"key":"48878_CR1","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/s00264-013-2201-1","volume":"38","author":"S Vukicevic","year":"2014","unstructured":"Vukicevic, S. et al. The clinical use of bone morphogenetic proteins revisited: A novel biocompatible carrier device OSTEOGROW for bone healing. Int. Orthop. 38, 635\u2013647. https:\/\/doi.org\/10.1007\/s00264-013-2201-1 (2014).","journal-title":"Int. Orthop."},{"key":"48878_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2020.115448","volume":"138","author":"L Grgurevic","year":"2020","unstructured":"Grgurevic, L. et al. Autologous blood coagulum containing rhBMP6 induces new bone formation to promote anterior lumbar interbody fusion (ALIF) and posterolateral lumbar fusion (PLF) of spine in sheep. Bone 138, 115448. https:\/\/doi.org\/10.1016\/j.bone.2020.115448 (2020).","journal-title":"Bone"},{"key":"48878_CR3","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1002\/term.2981","volume":"14","author":"S Vukicevic","year":"2020","unstructured":"Vukicevic, S. et al. Autologous blood coagulum is a physiological carrier for BMP6 to induce new bone formation and promote posterolateral lumbar spine fusion in rabbits. J. Tissue Eng. Regen. Med. 14, 147\u2013159. https:\/\/doi.org\/10.1002\/term.2981 (2020).","journal-title":"J. Tissue Eng. Regen. Med."},{"key":"48878_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2020.115551","volume":"140","author":"D Durdevic","year":"2020","unstructured":"Durdevic, D. et al. A novel autologous bone graft substitute comprised of rhBMP6 blood coagulum as carrier tested in a randomized and controlled Phase I trial in patients with distal radial fractures. Bone 140, 115551. https:\/\/doi.org\/10.1016\/j.bone.2020.115551 (2020).","journal-title":"Bone"},{"key":"48878_CR5","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1002\/jbmr.4107","volume":"35","author":"C Chiari","year":"2020","unstructured":"Chiari, C. et al. Recombinant human BMP6 applied within autologous blood coagulum accelerates bone healing: Randomized controlled trial in high tibial osteotomy patients. J. Bone Miner. Res. 35, 1893\u20131903. https:\/\/doi.org\/10.1002\/jbmr.4107 (2020).","journal-title":"J. Bone Miner. Res."},{"key":"48878_CR6","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1007\/s00264-020-04847-9","volume":"45","author":"N Stokovic","year":"2020","unstructured":"Stokovic, N. et al. Synthetic ceramic macroporous blocks as a scaffold in ectopic bone formation induced by recombinant human bone morphogenetic protein 6 within autologous blood coagulum in rats. Int. Orthop. 45, 1097\u20131107. https:\/\/doi.org\/10.1007\/s00264-020-04847-9 (2020).","journal-title":"Int. Orthop."},{"key":"48878_CR7","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1097\/00007632-199907150-00003","volume":"24","author":"H Itoh","year":"1999","unstructured":"Itoh, H. et al. Experimental spinal fusion with use of recombinant human bone morphogenetic protein 2. Spine (Phila Pa 1976) 24, 1402\u20131405. https:\/\/doi.org\/10.1097\/00007632-199907150-00003 (1999).","journal-title":"Spine (Phila Pa 1976)"},{"key":"48878_CR8","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.spinee.2008.06.452","volume":"9","author":"TE Mroz","year":"2009","unstructured":"Mroz, T. E. et al. The use of allograft bone in spine surgery: is it safe?. Spine J 9, 303\u2013308. https:\/\/doi.org\/10.1016\/j.spinee.2008.06.452 (2009).","journal-title":"Spine J"},{"key":"48878_CR9","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1016\/j.biomaterials.2009.11.050","volume":"31","author":"SV Dorozhkin","year":"2010","unstructured":"Dorozhkin, S. V. Bioceramics of calcium orthophosphates. Biomaterials 31, 1465\u20131485. https:\/\/doi.org\/10.1016\/j.biomaterials.2009.11.050 (2010).","journal-title":"Biomaterials"},{"key":"48878_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2020.115654","volume":"141","author":"N Stokovic","year":"2020","unstructured":"Stokovic, N. et al. Autologous bone graft substitute containing rhBMP6 within autologous blood coagulum and synthetic ceramics of different particle size determines the quantity and structural pattern of bone formed in a rat subcutaneous assay. Bone 141, 115654. https:\/\/doi.org\/10.1016\/j.bone.2020.115654 (2020).","journal-title":"Bone"},{"key":"48878_CR11","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.1007\/s00264-022-05546-3","volume":"46","author":"N Stokovic","year":"2022","unstructured":"Stokovic, N. et al. Comparison of synthetic ceramic products formulated with autologous blood coagulum containing rhBMP6 for induction of bone formation. Int. Orthop. 46, 2693\u20132704. https:\/\/doi.org\/10.1007\/s00264-022-05546-3 (2022).","journal-title":"Int. Orthop."},{"key":"48878_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9101487","author":"N Stokovic","year":"2021","unstructured":"Stokovic, N. et al. Zoledronate bound to ceramics increases ectopic bone volume induced by rhbmp6 delivered in autologous blood coagulum in rats. Biomedicines https:\/\/doi.org\/10.3390\/biomedicines9101487 (2021).","journal-title":"Biomedicines"},{"key":"48878_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2020.115544","volume":"140","author":"N Stokovic","year":"2020","unstructured":"Stokovic, N. et al. Evaluation of synthetic ceramics as compression resistant matrix to promote osteogenesis of autologous blood coagulum containing recombinant human bone morphogenetic protein 6 in rabbit posterolateral lumbar fusion model. Bone 140, 115544. https:\/\/doi.org\/10.1016\/j.bone.2020.115544 (2020).","journal-title":"Bone"},{"key":"48878_CR14","doi-asserted-by":"publisher","first-page":"11649","DOI":"10.1038\/s41598-022-14931-2","volume":"12","author":"N Stokovic","year":"2022","unstructured":"Stokovic, N. et al. Long-term posterolateral spinal fusion in rabbits induced by rhBMP6 applied in autologous blood coagulum with synthetic ceramics. Sci. Rep. 12, 11649. https:\/\/doi.org\/10.1038\/s41598-022-14931-2 (2022).","journal-title":"Sci. Rep."},{"key":"48878_CR15","doi-asserted-by":"publisher","first-page":"3513","DOI":"10.3390\/ma14133513","volume":"14","author":"N Stokovic","year":"2021","unstructured":"Stokovic, N., Ivanjko, N., Maticic, D., Luyten, F. P. & Vukicevic, S. Bone morphogenetic proteins, carriers, and animal models in the development of novel bone regenerative therapies. Materials 14, 3513. https:\/\/doi.org\/10.3390\/ma14133513 (2021).","journal-title":"Materials"},{"key":"48878_CR16","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1016\/j.spinee.2014.01.043","volume":"14","author":"MH Pelletier","year":"2014","unstructured":"Pelletier, M. H. et al. Lumbar spinal fusion with beta-TCP granules and variable Escherichia coli-derived rhBMP-2 dose. Spine J. 14, 1758\u20131768. https:\/\/doi.org\/10.1016\/j.spinee.2014.01.043 (2014).","journal-title":"Spine J."},{"key":"48878_CR17","doi-asserted-by":"publisher","first-page":"733","DOI":"10.3171\/2016.4.SPINE151316","volume":"25","author":"JM Toth","year":"2016","unstructured":"Toth, J. M., Wang, M., Lawson, J., Badura, J. M. & DuBose, K. B. Radiographic, biomechanical, and histological evaluation of rhBMP-2 in a 3-level intertransverse process spine fusion: An ovine study. J. Neurosurg. Spine 25, 733\u2013739. https:\/\/doi.org\/10.3171\/2016.4.SPINE151316 (2016).","journal-title":"J. Neurosurg. Spine"},{"key":"48878_CR18","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1097\/01.brs.0000240715.78657.81","volume":"31","author":"JR Dimar","year":"2006","unstructured":"Dimar, J. R., Glassman, S. D., Burkus, K. J. & Carreon, L. Y. Clinical outcomes and fusion success at 2 years of single-level instrumented posterolateral fusions with recombinant human bone morphogenetic protein-2\/compression resistant matrix versus iliac crest bone graft. Spine (Phila Pa 1976) 31, 2534\u20132539. https:\/\/doi.org\/10.1097\/01.brs.0000240715.78657.81 (2006).","journal-title":"Spine (Phila Pa 1976)"},{"key":"48878_CR19","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1097\/01.brs.0000172157.39513.80","volume":"30","author":"SD Glassman","year":"2005","unstructured":"Glassman, S. D. et al. Initial fusion rates with recombinant human bone morphogenetic protein-2\/compression resistant matrix and a hydroxyapatite and tricalcium phosphate\/collagen carrier in posterolateral spinal fusion. Spine (Phila Pa 1976) 30, 1694\u20131698. https:\/\/doi.org\/10.1097\/01.brs.0000172157.39513.80 (2005).","journal-title":"Spine (Phila Pa 1976)"},{"key":"48878_CR20","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1097\/01.BRS.0000048644.91330.14","volume":"28","author":"T Akamaru","year":"2003","unstructured":"Akamaru, T. et al. Simple carrier matrix modifications can enhance delivery of recombinant human bone morphogenetic protein-2 for posterolateral spine fusion. Spine (Phila Pa 1976) 28, 429\u2013434. https:\/\/doi.org\/10.1097\/01.BRS.0000048644.91330.14 (2003).","journal-title":"Spine (Phila Pa 1976)"},{"key":"48878_CR21","doi-asserted-by":"publisher","DOI":"10.1088\/1748-6041\/7\/3\/035002","volume":"7","author":"J Hou","year":"2012","unstructured":"Hou, J. et al. Segmental bone regeneration using rhBMP-2-loaded collagen\/chitosan microspheres composite scaffold in a rabbit model. Biomed. Mater. 7, 035002. https:\/\/doi.org\/10.1088\/1748-6041\/7\/3\/035002 (2012).","journal-title":"Biomed. Mater."},{"key":"48878_CR22","doi-asserted-by":"publisher","first-page":"242","DOI":"10.22203\/eCM.v035a17","volume":"35","author":"D Mumcuoglu","year":"2018","unstructured":"Mumcuoglu, D. et al. Injectable Bmp-2 delivery system based on collagen-derived microspheres and alginate induced bone formation in a time- and dose-dependent manner. Eur Cells Mater 35, 242\u2013254. https:\/\/doi.org\/10.22203\/eCM.v035a17 (2018).","journal-title":"Eur Cells Mater"},{"key":"48878_CR23","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1007\/s11095-017-2147-x","volume":"34","author":"I El Bialy","year":"2017","unstructured":"El Bialy, I., Jiskoot, W. & Reza Nejadnik, M. Formulation, delivery and stability of bone morphogenetic proteins for effective bone regeneration. Pharm. Res. 34, 1152\u20131170. https:\/\/doi.org\/10.1007\/s11095-017-2147-x (2017).","journal-title":"Pharm. Res."},{"key":"48878_CR24","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1002\/jbm.a.32957","volume":"96","author":"L Luca","year":"2011","unstructured":"Luca, L. et al. Injectable rhBMP-2-loaded chitosan hydrogel composite: Osteoinduction at ectopic site and in segmental long bone defect. J. Biomed. Mater. Res. A 96, 66\u201374. https:\/\/doi.org\/10.1002\/jbm.a.32957 (2011).","journal-title":"J. Biomed. Mater. Res. A"},{"key":"48878_CR25","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1089\/ten.2006.12.1305","volume":"12","author":"M Yamamoto","year":"2006","unstructured":"Yamamoto, M., Takahashi, Y. & Tabata, Y. Enhanced bone regeneration at a segmental bone defect by controlled release of bone morphogenetic protein-2 from a biodegradable hydrogel. Tissue Eng. 12, 1305\u20131311. https:\/\/doi.org\/10.1089\/ten.2006.12.1305 (2006).","journal-title":"Tissue Eng."},{"key":"48878_CR26","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1186\/s12891-016-1131-7","volume":"17","author":"KT Peng","year":"2016","unstructured":"Peng, K. T. et al. Treatment of critically sized femoral defects with recombinant BMP-2 delivered by a modified mPEG-PLGA biodegradable thermosensitive hydrogel. BMC Musculoskelet. Disord. 17, 286. https:\/\/doi.org\/10.1186\/s12891-016-1131-7 (2016).","journal-title":"BMC Musculoskelet. Disord."},{"key":"48878_CR27","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1097\/01.brs.0000172155.17239.fa","volume":"30","author":"T Namikawa","year":"2005","unstructured":"Namikawa, T. et al. Experimental spinal fusion with recombinant human bone morphogenetic protein-2 delivered by a synthetic polymer and beta-tricalcium phosphate in a rabbit model. Spine (Phila Pa 1976) 30, 1717\u20131722. https:\/\/doi.org\/10.1097\/01.brs.0000172155.17239.fa (2005).","journal-title":"Spine (Phila Pa 1976)"},{"key":"48878_CR28","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.actbio.2017.06.041","volume":"59","author":"KC Huang","year":"2017","unstructured":"Huang, K. C. et al. Sandwich-type PLLA-nanosheets loaded with BMP-2 induce bone regeneration in critical-sized mouse calvarial defects. Acta Biomater. 59, 12\u201320. https:\/\/doi.org\/10.1016\/j.actbio.2017.06.041 (2017).","journal-title":"Acta Biomater."},{"key":"48878_CR29","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1097\/00007632-199906150-00002","volume":"24","author":"SD Boden","year":"1999","unstructured":"Boden, S. D., Martin, G. J. Jr., Morone, M. A., Ugbo, J. L. & Moskovitz, P. A. Posterolateral lumbar intertransverse process spine arthrodesis with recombinant human bone morphogenetic protein 2\/hydroxyapatite-tricalcium phosphate after laminectomy in the nonhuman primate. Spine (Phila Pa 1976) 24, 1179\u20131185. https:\/\/doi.org\/10.1097\/00007632-199906150-00002 (1999).","journal-title":"Spine (Phila Pa 1976)"},{"key":"48878_CR30","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1007\/s00776-003-0749-0","volume":"9","author":"A Minamide","year":"2004","unstructured":"Minamide, A. et al. Experimental study of carriers of bone morphogenetic protein used for spinal fusion. J. Orthop. Sci. 9, 142\u2013151. https:\/\/doi.org\/10.1007\/s00776-003-0749-0 (2004).","journal-title":"J. Orthop. Sci."},{"key":"48878_CR31","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1016\/S0736-0266(02)00011-6","volume":"20","author":"J Louis-Ugbo","year":"2002","unstructured":"Louis-Ugbo, J. et al. Retention of 125I-labeled recombinant human bone morphogenetic protein-2 by biphasic calcium phosphate or a composite sponge in a rabbit posterolateral spine arthrodesis model. J. Orthop. Res. 20, 1050\u20131059. https:\/\/doi.org\/10.1016\/S0736-0266(02)00011-6 (2002).","journal-title":"J. Orthop. Res."},{"key":"48878_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.bonr.2020.100739","volume":"14","author":"TY Huang","year":"2021","unstructured":"Huang, T. Y., Wu, C. C., Weng, P. W., Chen, J. M. & Yeh, W. L. Effect of ErhBMP-2-loaded beta-tricalcium phosphate on ulna defects in the osteoporosis rabbit model. Bone Rep. 14, 100739. https:\/\/doi.org\/10.1016\/j.bonr.2020.100739 (2021).","journal-title":"Bone Rep."},{"key":"48878_CR33","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1007\/s00264-018-4079-4","volume":"43","author":"Y Kuroiwa","year":"2019","unstructured":"Kuroiwa, Y. et al. Escherichia coli-derived BMP-2-absorbed beta-TCP granules induce bone regeneration in rabbit critical-sized femoral segmental defects. Int. Orthop. 43, 1247\u20131253. https:\/\/doi.org\/10.1007\/s00264-018-4079-4 (2019).","journal-title":"Int. Orthop."},{"key":"48878_CR34","doi-asserted-by":"publisher","first-page":"3206","DOI":"10.1007\/s11999-009-0960-1","volume":"467","author":"S Dohzono","year":"2009","unstructured":"Dohzono, S., Imai, Y., Nakamura, H., Wakitani, S. & Takaoka, K. Successful spinal fusion by E. coli-derived BMP-2-adsorbed porous beta-TCP granules: a pilot study. Clin. Orthop. Relat. Res. 467, 3206\u20133212. https:\/\/doi.org\/10.1007\/s11999-009-0960-1 (2009).","journal-title":"Clin. Orthop. Relat. Res."},{"key":"48878_CR35","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1007\/s00774-011-0329-x","volume":"30","author":"Y Harada","year":"2012","unstructured":"Harada, Y. et al. Effect of Escherichia coli-produced recombinant human bone morphogenetic protein 2 on the regeneration of canine segmental ulnar defects. J Bone Miner Metab 30, 388\u2013399. https:\/\/doi.org\/10.1007\/s00774-011-0329-x (2012).","journal-title":"J Bone Miner Metab"},{"key":"48878_CR36","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/S0736-0266(02)00205-X","volume":"21","author":"FC den Boer","year":"2003","unstructured":"den Boer, F. C. et al. Healing of segmental bone defects with granular porous hydroxyapatite augmented with recombinant human osteogenic protein-1 or autologous bone marrow. J. Orthop. Res. 21, 521\u2013528. https:\/\/doi.org\/10.1016\/S0736-0266(02)00205-X (2003).","journal-title":"J. Orthop. Res."},{"key":"48878_CR37","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.spinee.2012.01.013","volume":"12","author":"JH Lee","year":"2012","unstructured":"Lee, J. H. et al. Comparative study of fusion rate induced by different dosages of Escherichia coli-derived recombinant human bone morphogenetic protein-2 using hydroxyapatite carrier. Spine J 12, 239\u2013248. https:\/\/doi.org\/10.1016\/j.spinee.2012.01.013 (2012).","journal-title":"Spine J"},{"key":"48878_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2020.115511","volume":"138","author":"J Lammens","year":"2020","unstructured":"Lammens, J. et al. A cell-based combination product for the repair of large bone defects. Bone 138, 115511. https:\/\/doi.org\/10.1016\/j.bone.2020.115511 (2020).","journal-title":"Bone"},{"key":"48878_CR39","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1016\/s0142-9612(00)00322-7","volume":"22","author":"MI Alam","year":"2001","unstructured":"Alam, M. I. et al. Evaluation of ceramics composed of different hydroxyapatite to tricalcium phosphate ratios as carriers for rhBMP-2. Biomaterials 22, 1643\u20131651. https:\/\/doi.org\/10.1016\/s0142-9612(00)00322-7 (2001).","journal-title":"Biomaterials"},{"key":"48878_CR40","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1007\/s00264-019-04322-0","volume":"43","author":"S Vukicevic","year":"2019","unstructured":"Vukicevic, S., Stokovic, N. & Pecina, M. Is ceramics an appropriate bone morphogenetic protein delivery system for clinical use?. Int. Orthop. 43, 1275\u20131276. https:\/\/doi.org\/10.1007\/s00264-019-04322-0 (2019).","journal-title":"Int. Orthop."},{"key":"48878_CR41","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1097\/00007632-200202150-00006","volume":"27","author":"DY Suh","year":"2002","unstructured":"Suh, D. Y. et al. Delivery of recombinant human bone morphogenetic protein-2 using a compression-resistant matrix in posterolateral spine fusion in the rabbit and in the non-human primate. Spine (Phila Pa 1976) 27, 353\u2013360. https:\/\/doi.org\/10.1097\/00007632-200202150-00006 (2002).","journal-title":"Spine (Phila Pa 1976)"},{"key":"48878_CR42","doi-asserted-by":"publisher","first-page":"756","DOI":"10.3109\/17453674.2011.636675","volume":"82","author":"JW Lee","year":"2011","unstructured":"Lee, J. W. et al. Improved spinal fusion efficacy by long-term delivery of bone morphogenetic protein-2 in a rabbit model. Acta Orthop. 82, 756\u2013760. https:\/\/doi.org\/10.3109\/17453674.2011.636675 (2011).","journal-title":"Acta Orthop."},{"key":"48878_CR43","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1292\/jvms.60.451","volume":"60","author":"T Itoh","year":"1998","unstructured":"Itoh, T. et al. Repair of ulnar segmental defect by recombinant human bone morphogenetic protein-2 in dogs. J. Vet. Med. Sci. 60, 451\u2013458. https:\/\/doi.org\/10.1292\/jvms.60.451 (1998).","journal-title":"J. Vet. Med. Sci."},{"key":"48878_CR44","doi-asserted-by":"publisher","first-page":"9960","DOI":"10.1016\/j.biomaterials.2013.09.011","volume":"34","author":"A Cipitria","year":"2013","unstructured":"Cipitria, A. et al. Polycaprolactone scaffold and reduced rhBMP-7 dose for the regeneration of critical-sized defects in sheep tibiae. Biomaterials 34, 9960\u20139968. https:\/\/doi.org\/10.1016\/j.biomaterials.2013.09.011 (2013).","journal-title":"Biomaterials"},{"key":"48878_CR45","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1007\/s00132-011-1855-x","volume":"41","author":"JC Reichert","year":"2012","unstructured":"Reichert, J. C. et al. Bone tissue engineering. Reconstruction of critical sized segmental bone defects in the ovine tibia. Orthopade 41, 280\u2013287. https:\/\/doi.org\/10.1007\/s00132-011-1855-x (2012).","journal-title":"Orthopade"},{"key":"48878_CR46","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.biomaterials.2015.03.057","volume":"56","author":"M Yamamoto","year":"2015","unstructured":"Yamamoto, M. et al. Combination of BMP-2-releasing gelatin\/beta-TCP sponges with autologous bone marrow for bone regeneration of X-ray-irradiated rabbit ulnar defects. Biomaterials 56, 18\u201325. https:\/\/doi.org\/10.1016\/j.biomaterials.2015.03.057 (2015).","journal-title":"Biomaterials"},{"key":"48878_CR47","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1002\/jbm.b.34018","volume":"106","author":"Z Pan","year":"2018","unstructured":"Pan, Z. et al. Repair of a critical-size segmental rabbit femur defect using bioglass-beta-TCP monoblock, a vascularized periosteal flap and BMP-2. J. Biomed. Mater. Res. B Appl. Biomater. 106, 2148\u20132156. https:\/\/doi.org\/10.1002\/jbm.b.34018 (2018).","journal-title":"J. Biomed. Mater. Res. B Appl. Biomater."},{"key":"48878_CR48","doi-asserted-by":"publisher","first-page":"26","DOI":"10.21857\/mnlqgc5vgy","volume":"544","author":"S Vukicevic","year":"2020","unstructured":"Vukicevic, S. et al. Bone morphogenetic proteins: From discovery to development of a novel autologous bone graft substitute consisting of recombinant human BMP6 delivered in autologous blood coagulum carrier. Rad CASA Med. Sci. 544, 26\u201341. https:\/\/doi.org\/10.21857\/mnlqgc5vgy (2020).","journal-title":"Rad CASA Med. Sci."},{"key":"48878_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2020.115602","volume":"141","author":"TK Sampath","year":"2020","unstructured":"Sampath, T. K. & Vukicevic, S. Biology of bone morphogenetic protein in bone repair and regeneration: A role for autologous blood coagulum as carrier. Bone 141, 115602. https:\/\/doi.org\/10.1016\/j.bone.2020.115602 (2020).","journal-title":"Bone"},{"key":"48878_CR50","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1097\/00007632-200005010-00003","volume":"25","author":"HG Baramki","year":"2000","unstructured":"Baramki, H. G., Steffen, T., Lander, P., Chang, M. & Marchesi, D. The efficacy of interconnected porous hydroxyapatite in achieving posterolateral lumbar fusion in sheep. Spine (Phila Pa 1976) 25, 1053\u20131060. https:\/\/doi.org\/10.1097\/00007632-200005010-00003 (2000).","journal-title":"Spine (Phila Pa 1976)"},{"key":"48878_CR51","doi-asserted-by":"publisher","DOI":"10.1002\/jbm4.10085","volume":"3","author":"L Grgurevic","year":"2019","unstructured":"Grgurevic, L. et al. Recombinant human bone morphogenetic protein 6 delivered within autologous blood coagulum restores critical size segmental defects of ulna in rabbits. JBMR Plus 3, e10085. https:\/\/doi.org\/10.1002\/jbm4.10085 (2019).","journal-title":"JBMR Plus"},{"key":"48878_CR52","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1902\/jop.2006.050268","volume":"77","author":"UW Jung","year":"2006","unstructured":"Jung, U. W. et al. The effect of varying the particle size of beta tricalcium phosphate carrier of recombinant human bone morphogenetic protein-4 on bone formation in rat calvarial defects. J. Periodontol. 77, 765\u2013772. https:\/\/doi.org\/10.1902\/jop.2006.050268 (2006).","journal-title":"J. Periodontol."},{"key":"48878_CR53","doi-asserted-by":"publisher","first-page":"12169","DOI":"10.1074\/jbc.M109.087197","volume":"285","author":"K Song","year":"2010","unstructured":"Song, K. et al. Identification of a key residue mediating bone morphogenetic protein (BMP)-6 resistance to noggin inhibition allows for engineered BMPs with superior agonist activity. J. Biol. Chem. 285, 12169\u201312180. https:\/\/doi.org\/10.1074\/jbc.M109.087197 (2010).","journal-title":"J. Biol. Chem."},{"key":"48878_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.bonr.2021.100759","volume":"14","author":"M Pecin","year":"2021","unstructured":"Pecin, M. et al. A novel autologous bone graft substitute containing rhBMP6 in autologous blood coagulum with synthetic ceramics for reconstruction of a large humerus segmental gunshot defect in a dog: the first veterinary patient to receive a novel osteoinductive therapy. Bone Rep 14, 100759. https:\/\/doi.org\/10.1016\/j.bonr.2021.100759 (2021).","journal-title":"Bone Rep"},{"key":"48878_CR55","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0150102","volume":"11","author":"I Erjavec","year":"2016","unstructured":"Erjavec, I. et al. Constitutively elevated blood serotonin is associated with bone loss and type 2 diabetes in rats. PLoS One 11, e0150102. https:\/\/doi.org\/10.1371\/journal.pone.0150102 (2016).","journal-title":"PLoS One"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-48878-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-48878-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-48878-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,12]],"date-time":"2023-12-12T18:11:18Z","timestamp":1702404678000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-48878-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,12]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["48878"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-48878-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,12]]},"assertion":[{"value":"26 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S.V. is a founder of Genera Research and a coordinator of the EU HORIZON 2020 Grant OSTEOproSPINE funding clinical studies of the new drug for bone repair (patent WO2019076484A1).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"22079"}}